benefits

From Dominance to Compliance

Source Node:
Time Stamp: December 3, 2023 1:05 PM - Modified On: December 3, 2023 - Published By:
Source Cluster:
Republished By Plato

Last Tuesday saw Binance settle its long-running legal disputes with several U.S. government agencies, including the Department of Justice (DoJ), the Department of the Treasury’s Financial Crimes Enforcement Network (FinCEN), the Office of Foreign Assets Control (OFAC), and the U.S. Commodity Futures Trading Commission (CFTC). However, they failed to reach an agreement with the Securities and Exchange Commission (SEC) regarding their pending charges. As part of the settlement, Binance has agreed to pay an eye-popping fine of $4.3 billion. Furthermore, Changpeng Zhao (CZ), the CEO of Binance, will step down

Skale x Cryptopia Making Free-to-play-and-earn A Reality For Gamers

Source Node:
Time Stamp: November 21, 2023 6:13 AM - Modified On: November 21, 2023 - Published By:
Source Cluster:
Republished By Plato

Nov 21, 2023. Tortola, British Virgin Islands. With great excitement, we are pleased to announce our partnership with Skale, a zero-gas fee EVM blockchain. As a pioneering free-to-play-and-earn game that embodies the spirit of a new era in gaming, this alliance is set to transform the gaming landscape by empowering players to combine fun and earning opportunities without the constraints of excessive fees or financial barriers. We are living in exciting times. Gradually, we are entering an era where games are not only for fun but also offer a seamless

NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.

Source Node:
Time Stamp: October 24, 2023 11:55 AM - Modified On: October 24, 2023 - Published By:
Source Cluster:
Republished By Plato

Summary: Progress in Neurodegenerative Research:  NKGen’s Phase 1/2a Clinical Trial for SNK01 on Track for End-of-Year Initiation SANTA ANA, Calif., Oct. 24, 2023 (Plato / Amplifi) -- Today, NKGen Biotech Inc. (Nasdaq: NKGN), a trailblazer in the field of autologous, allogeneic, and CAR-NK natural killer cell therapeutics, proudly announced the progression of its SNK01 program targeting Alzheimer’s Disease (AD), backed by the green light from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application. NKGen is gearing up to initiate its Phase 1/2a clinical trial

BANTgo and Verofax Team Up to Revolutionize E-waste Collection Through Tokenized Rewards

Source Node:
Time Stamp: October 24, 2023 7:04 AM - Modified On: October 24, 2023 - Published By:
Source Cluster:
Republished By Plato

DUBAI, Oct 24, 2023 - (ACN Newswire) - In an ambitious stride towards environmental sustainability, BANTgo and Verofax have announced a pioneering collaboration to enhance e-waste collection. The groundbreaking partnership seeks to galvanize the masses into responsible recycling by rewarding their endeavors with tokenized incentives. Verofax, was awarded the GITEX Supernova Web3 and Blockchain award, introduces its innovative technology to this eco-initiative. The venture encompasses the deployment of advanced smart bins explicitly designed for e-waste collection. These bins are equipped with a validation system to ensure accurate assessment of the

Revolutionizing Tourism with Web3: A Landmark Partnership Between Camino Network, DCM Swiss, 1World Online, and Web3-Solutions

Source Node:
Time Stamp: October 12, 2023 12:02 PM - Modified On: October 12, 2023 - Published By:
Source Cluster:
Republished By Plato

In an unprecedented-opportunity-driven move, four innovative companies in the travel and marketing sectors — Camino Network, initiated by Chain4Travel, DCM Swiss, 1World Online, and Web3-Solutions — have come together to announce a landmark partnership. This alliance aims to harness cutting-edge technologies in reshaping the future of travel and tourism experiences and bringing new monetization options and benefits to all ecosystem participants. We are happy to announce that: DCM Swiss and 1World Online are becoming Validators at Camino Network. Web3-Solutions becomes a Regional Partner of DCM: A regional partnership agreement has

Zumo first to launch platform built to meet the tech requirements of the FCA’s new Financial Promotions Regime for Crypto Assets

Source Node:
Time Stamp: October 6, 2023 7:12 AM - Modified On: October 6, 2023 - Published By:
Source Cluster:
Republished By Plato

  The award-winning platform has set a new benchmark in consumer protection and regulatory alignment With some UK operators having to pause activity, Zumo’s financial promotions technical flow is now also available through its B2B API to support unregistered firms with remaining compliant after the 8 October deadline [London/Edinburgh - Friday 29 September 2023] Zumo, the UK-based digital-asset-as-a-service platform, has announced a significant industry milestone as it becomes the first digital asset platform to have integrated tech based requirements of the Financial Conduct Authority’s (FCA’s) new financial promotions regime for

HealthCare AI: The Unavoidable Revolution in Modern Medicine

Source Node:
Time Stamp: October 5, 2023 3:40 PM - Modified On: October 5, 2023 - Published By:
Source Cluster:
Republished By Plato

By Eric Greenberg www.linkedin.com/in/ericabg In the evolving landscape of medical technology, there's one force that stands head and shoulders above the rest, promising a seismic shift in the very ethos of healthcare delivery: Artificial Intelligence (AI). As a seasoned technology and banking analyst, it is my considered opinion that Healthcare AI isn't just a trend or a buzzword. It’s the very future of medicine, poised to reshape everything we know about patient care, disease diagnosis, and medical research. To begin with, the economic implications of integrating AI in healthcare are

Revolutionizing Clinical Trials: The Digital Watermarking and AI Duo

Source Node:
Time Stamp: October 5, 2023 11:22 AM - Modified On: October 5, 2023 - Published By:
Source Cluster:
Republished By Plato

Revolutionizing Clinical Trials: The Digital Watermarking and AI Duo Clinical trials, the linchpin of medical research, have long been riddled with inefficiencies, from patient recruitment bottlenecks to data management hurdles. As a technology and banking analyst, I've seen how digital solutions can overhaul entire sectors, offering improved productivity and streamlined processes. It's high time that clinical trials get a dose of such digital innovation, and there's a potent combination on the horizon: digital watermarking coupled with Artificial Intelligence (AI). At first glance, one might wonder: how can a technique often

The Convergence of MedTech and Blockchain: Transforming Healthcare

Source Node:
Time Stamp: September 14, 2023 4:39 PM - Modified On: September 14, 2023 - Published By:
Source Cluster:
Republished By Plato

The healthcare industry has witnessed a remarkable transformation driven by technological advancements in recent years. One groundbreaking convergence is the fusion of Medical Technology (MedTech) and blockchain technology. This synergy has the potential to revolutionize healthcare by enhancing data security, interoperability, and patient-centric care. Enhanced Data Security: One of the foremost challenges in healthcare is ensuring the security and privacy of patient data. Medical records contain sensitive information that must be protected from unauthorized access and cyber threats. Blockchain technology offers a robust solution to this problem. Blockchain operates on

ESG1 Partners with GMEX ZERO13 on Trading Tokenized Carbon Credits from Emissions Removals

Source Node:
Time Stamp: September 13, 2023 2:00 AM - Modified On: September 14, 2023 - Published By:
Source Cluster:
Republished By Plato

Cross-chain interoperable ESG asset trading and settlement enabled by ZERO13 as a fully integrated market distribution partner for ESG1’s highly verified, IoT-linked industrial carbon credit tokens. London and Calgary, 14 September 2023: ZERO13, a GMEX Group initiative providing a digital climate fintech aggregation ecosystem, and ESG1, a subsidiary of GuildOne providing innovative digital assets and ESG solutions built on R3’s Corda, have announced a landmark collaboration that will create an automated digital pipeline for North American industrial carbon offsets to reach high-demand markets in Europe and the Middle East. ESG1’s

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Source Node:
Time Stamp: August 29, 2023 8:20 AM - Modified On: August 29, 2023 - Published By:
Source Cluster:
Republished By Plato

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement

Clockout Breaks New Ground in Wage Access. Launches and Expands its Reach to 42 States

Source Node:
Time Stamp: August 18, 2023 3:28 PM - Modified On: August 18, 2023 - Published By:
Source Cluster:
Republished By Plato

Historically, on-demand wage access required significant backend adjustments, coordination and often posed integration hurdles for employers. Clockout, a cutting-edge fintech platform, is pushing the boundaries of the traditional earned wage access model. In a bold move to address common industry challenges, the company has unveiled a streamlined, implementation-free model for employers, eliminating the need for cumbersome contracts and implementations and making offering their workforce immediate access to earned wages effortless. Clockout amplifies businesses' employee motivation, retention, and hiring leverage; while placing the power directly in the hands of the employees